(4-Bromo-2-fluoro-5-(trifluoromethyl)phenyl)boronic acid, 96%, 250mg

4-Methoxyisoxazole-3-carboxylic acid, 98%, 500mg

4-Butylbenzyl Bromide>97.0%(GC)5g

5-(5-Chlorothiophen-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 1g

l-Cysteinol(bzl), 95.0%, 1g

(S)-2-N-Boc-Amino-1-pyrrolidin-1-yl-propan-1-one, 97.0%, 1g

2-Bromo-3-(chloromethyl)pyridine, 95.0%, 1g

1-(BENZYLOXY)-4-(2-IODOETHYL)BENZENE, 95%, 250mg

6-Amino-2-(butylamino)-9-[[6-[2-(dimethylamino)ethoxy]-3-pyridinyl]methyl]-7,9-dihydro-8H-purin-8-one, 10mg

6,7-Dichloroquinoxaline-2,3(1H,4H)-dione, 95.0%, 5g

Chromatography columns without frit, 35 ml, 15 mm, 200 mm, 1 Piece(s)

Potassium metaborate hydrate, = 31% as B2O3 & = 42% as K2O, 5g

2,4-Dimethylbenzonitrile, 97.0%, 10g